Latest Breaking News On - Td chi memorial - Page 1 : comparemela.com

/PRNewswire/ Lumosa Therapeutics (Lumosa; 6535.TWO), together with CHI Memorial have announced the initiation of a Phase 2b clinical trial for LT3001, a.

United statesT ai peiChattanooga centerLumosa therapeutics co ltdMemorial neuroscience instituteNeurologic researchCritical unmetNeuroscience instituteLumosa therapeutics coTd chi memorial